Kala Pharmaceuticals to sell 1.197M shares at $5.85 in private placement
PremiumThe FlyKala Pharmaceuticals to sell 1.197M shares at $5.85 in private placement
2M ago
KALA BIO to Present at Jefferies Global Healthcare Conference
Premium
Press Releases
KALA BIO to Present at Jefferies Global Healthcare Conference
3M ago
Kala Pharmaceuticals price target lowered to $18 from $21 at H.C. Wainwright
Premium
The Fly
Kala Pharmaceuticals price target lowered to $18 from $21 at H.C. Wainwright
3M ago
KALA Pharmaceuticals Spotlights Ophthalmology Advances
PremiumCompany AnnouncementsKALA Pharmaceuticals Spotlights Ophthalmology Advances
6M ago
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
Premium
Press Releases
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
6M ago
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Premium
Press Releases
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
7M ago
Kala Pharmaceuticals reports Q2 EPS ($3.41), consensus ($2.15)
PremiumThe FlyKala Pharmaceuticals reports Q2 EPS ($3.41), consensus ($2.15)
9M ago
KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Premium
Press Releases
KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update
9M ago
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Premium
Press Releases
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100